Sormani MP, Häring DA, Kropshofer H, et al. Blood NfL as a potential endpoint in Phase 2 clinical studies in relapsing-remitting multiple sclerosis. ECTRIMS 2017, 277.
Evolutie of revolutie in alzheimeronderzoek: de afscheidsrede van Philip Scheltens
aug 2023 | Dementie